You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

5 Results
Guidelines and Advice
Status: Archived
ID: 1-1
Version: 3
Sep 2011
Guidelines and Advice
Guidelines and Advice
Status: Archived
ID: 8-5
Version: 2
Sep 2011
Drug
Other Name(s): Sutent®
Sep 2023
Regimen
Cancer Type:
Hematologic, 
Lymphoma - T-cell
Intent: Curative
Funding:
New Drug Funding Program
    Pegaspargase - Extranodal Natural Killer/T-cell Lymphoma
Sep 2023